LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Arrowstreet Capital, Limited Partnership (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

(Reuters) -Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from the use of Tylenol by pregnant women. The October 28 lawsuit against Kenvue and its former parent Johnson & Johnson, which made Tylenol for...

Overview * Rallybio ( RLYB ) reports Q3 net income of $16.0 mln, reversing a loss from last year * Company generated $20 mln from sale of interest in REV102 * Cash runway extended through 2027, ensuring financial stability Outlook * Rallybio ( RLYB ) expects to report RLYB116 study data in 4Q 2025 * Company's cash runway extended through...

Overview * VYNE Q3 net loss decreases compared to last year * Company progressing with strategic review to maximize shareholder value Outlook * VYNE is conducting a strategic review to explore options like partnerships or mergers * Company expects cash runway to last into the first half of 2027 * VYNE is conducting a 12-week toxicology study for VYN202 to...